These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12752518)

  • 1. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Increasing the Dose of Abobotulinumtoxina Impact the Duration of Effectiveness for the Treatment of Moderate to Severe Glabellar Lines?
    Joseph JH; Eaton LL; Robinson J; Pontius A; Williams EF
    J Drugs Dermatol; 2016 Dec; 15(12):1544-1549. PubMed ID: 29106437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
    Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R
    Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep resting glabellar rhytides respond to BTX-A and Hylan B.
    Carruthers J; Carruthers A; Maberley D
    Dermatol Surg; 2003 May; 29(5):539-44. PubMed ID: 12752525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum A toxin for glabellar wrinkles. Dose and response.
    Hankins CL; Strimling R; Rogers GS
    Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC; Carruthers JA; Carruthers JA; Clark RE
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study.
    Yoelin SG; Dhawan SS; Vitarella D; Ahmad W; Hasan F; Abushakra S
    Plast Reconstr Surg; 2018 Dec; 142(6):847e-855e. PubMed ID: 30489516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis.
    Spencer JM; Gordon M; Goldberg DJ
    J Cosmet Laser Ther; 2002 Mar; 4(1):19-23. PubMed ID: 12079633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
    Flynn TC; Clark RE
    Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.